GE HealthCare Technologies Inc.

GEHC Healthcare Medical Devices

GE HealthCare Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $20.6 billion, up 4.84% from fiscal 2024. In the quarter to June 2026, revenue grew 5.75%, EPS grew 17.0%, free cash flow grew 750.0% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; dividend growth for three consecutive years, revenue growth for five; insiders bought in the last twelve months.

69.57 0.78 −1.11%
Market cap
$31.8B
P/E
16.0×
Fwd P/E
14.4×
Dividend yield
0.26%
F-score
4/9
Altman Z
1.96
Beneish M
−2.33
Dividend safety
74/100

GE HealthCare Technologies Inc. (GEHC) Revenue

Alert me on Revenue

GE HealthCare Technologies Inc.'s revenue for fiscal 2025 was $20.6B, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $21.3B. Over the past ten years it has ranged from $16.6B (fiscal 2019) to $20.6B (fiscal 2025) — the current reading is the highest in ten years. Revenue has risen for 6 consecutive fiscal years. GE HealthCare Technologies Inc. ranks 4th of 140 Medical Devices companies by revenue.

Revenue, annual

Embed this chart

Annual newest first

Period Revenue Change
FY2025 $20.6B 4.84%
FY2024 $19.7B 0.61%
FY2023 $19.6B 6.60%
FY2022 $18.3B 4.30%
FY2021 $17.6B 2.45%
FY2020 $17.2B 3.19%
FY2019 $16.6B —

Quarterly newest first

Period Revenue Change
Jun 2026 $5.3B 3.20%
Mar 2026 $5.1B (9.95%)
Dec 2025 $5.7B 10.79%
Sep 2025 $5.1B 2.72%
14 more quarters

Against its own ten years

Low $16.6B High $20.6B
Ten-year median $18.3B
Current reading's percentile 100

Revenue against peers

What Revenue is

Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.

Reported line item

The full definition of Revenue →

More on GEHC